Overexpression of LIMK1 promotes migration ability of multidrug-resistant osteosarcoma cells

Oncology Research

Volumn 19, Issue 10-11, 2012, Pages 501-509

  Zhang, Hanyang ^a   Wang, Yan ^a   Xing, Fengjuan ^a   Wang, Jincheng ^a   Wang, Yang ^a   Wang, Hong ^a   Yang, Yudan ^a   Gao, Zhongli ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

LIMK1; MG63; Migration; Multidrug resistance; Osteosarcoma; Vincristine

Indexed keywords

COFILIN; DOXORUBICIN; LIM KINASE 1; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; PROTEIN BCL 2; VINCRISTINE;

ACTIN FILAMENT; ARTICLE; CANCER INVASION; CONTROLLED STUDY; DRUG TARGETING; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; METASTASIS; METASTASIS POTENTIAL; MULTIDRUG RESISTANCE; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

EID: 84859701076     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/096504012X13286534482511     Document Type: Article

References (21)

1. Rosen, G. Neoadjuvant chemotherapy for osteogenic sarcoma: A model for the treatment of other highly malignant neoplasms. Cancer Res. 103:148-157; 1986.
2. Schwartz, C. L.; Gorlick, R.; Teot, L.; Krailo, M.; Chen, Z.; Goorin, A.; Grier, H. E.; Bernstein, M. L.; Meyers, P. Multiple drug resistance in osteogenic sarcoma: Children's Oncology Group. J. Clin. Oncol. 25:2057-2062; 2007.
3. Yang, N.; Higuchi, O.; Ohashi, K.; Nagata, K.; Wada, A.; Kangawa, K.; Nishida, E.; Mizuno, K. Cofilin phosphorylation by LIM-kinase 1 and its role in Rac-mediated actin reorganization. Nature 393:809-812; 1998.
4. Arber, S.; Barbayannis, F. A.; Hanser, H.; Schneider, C.; Stanyon, C. A.; Bernard, O.; Caroni, P. Regulation of actin dynamics through phosphorylation of cofilin by LIM-kinase. Nature 393:805-809; 1998.
5. Leonard, G. D.; Fojo, T.; Bates, S. E. The role of ABC transporters in clinical practice. Oncologist 8:411-424; 2003.
6. Choi, C. H. ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal. Cancer Cell Int. 5:30-43; 2005.
7. Ullah, M. F. Cancer multidrug resistance (MDR): A major impediment to effective chemotherapy. Asian Pac. J. Cancer Prev. 9:1-16; 2008.
8. Hait, W. N.; Yang, J. M. Clinical management of recurrent breast cancer: Development of multidrug resistance (MDR) andstrategies to circumvent it. Semin. Oncol. 32: 16-21; 2005.
9. Peng, Z.; Ling, G.; Sun, J. Multifunctional nanoassemblies for vincristinee sulfate delivery to overcome multidrug resistance by escaping P-glycoprotein mediated efflux. Biomaterials 32:5524-5533; 2011.
10. Hildebrand, J. L.; Bains, O. S.; Lee, D. S. Functional and energetic characterization of P-gp mediated doxorubicin- transport in rainbow trout (Oncorhynchus mykiss) hepatocytes. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 149:65-72; 2009.
11. Lagas, J. S.; Fan, L.; Wagenaar, E. P-glycoprotein (P-gp/ Abcb1), Abcc2, and Abcc3 determine the pharmacokinetics of etoposide. Clin. Cancer Res. 16:130-140; 2010.
12. Li, L.; Jiang, A. C.; Dong, P. MDR1/P-gp and VEGF synergistically enhance the invasion of Hep-2 cells with multidrug resistance induced by Taxol. Ann. Surg. Oncol. 16: 1421-1428; 2009.
13. Grant, C. E.; Valdimarsson, G.; Hipfner, D. R.; Almquist, K. C.; Cole, S. P. C.; Deeley, R. G. Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res. 54:357-361; 1994.
14. Salinas-Souza, C.; Petrilli, A. S.; Toledo, S. R. Glutathione S-transferase polymorphisms in osteosarcoma patients. Pharmacogenet. Genomics 20:507-515; 2010.
15. Xue, C.; Haber, M.; Flemming, C. p53 determines multidrug sensitivity of childhood neuroblastoma. Cancer Res. 67:10351-10360; 2007.
16. Khodadadian, M.; Leroux, M. E.; Auzenne, E. MRP- and Bcl-2-mediated drug resistance in human SCLC: Effects of apoptotic sphingolipids in vitro. Lung Cancer 66:48-57; 2009.
17. Tenekua, T.; Ottman, R.; Chakrabarti, R. LIM kinase1 modulates function of membrane type matrix metalloproteinase 1: Implication in invasion of prostate cancer cells. Mol. Cancer 10:6-21; 2011.
18. Vlecken, D. H.; Bagowski, C. P. LIMK1 and LIMK2 are important for metastatic behavior and tumor cell-induced angiogenesis of pancreatic cancer cells. Zebrafish 6:433- 439; 2009.
19. Gorovoy, M.; Niu, J.; Bernard, O.; Profirovic, J.; Minshall, R.; Neamu, R.; Voyno-Yasenetskaya, T. LIM kinase 1 coordinates microtubule stability and actin polymerization in human endothelial cells. J. Biol. Chem. 280: 26533-26542; 2005.
20. Davila, M.; Frost, A. R.; Grizzle, W. E.; Chakrabarti, R. LIM kinase 1 is essential for the invasive growth of prostate epithelial cells: Implications in prostate cancer. J. Biol. Chem. 278:36868-36875; 2003.
21. Bagheri-Yarmand, R.; Mazumdar, A.; Sahin, A. A.; Kumar, R. LIM kinase 1 increases tumor metastasis of human breast cancer cells via regulation of the urokinase-type plasminogen activator system. Int. J. Cancer 118: 2703-2710; 2006.